(Q39754750)

14 September 2017

title

Lysophosphatidic acid (LPA) effects on endometrial carcinoma in vitro proliferation, invasion, and matrix metalloproteinase activity (English)

1 reference

14 September 2017

main subject

endometrial carcinoma

1 reference

3

1 reference

14 September 2017

Feng-qiang Wang

1

1 reference

14 September 2017

Edgardo V Ariztia

2

1 reference

14 September 2017

Faith R Horton

4

1 reference

14 September 2017

Yoel Smicun

5

1 reference

14 September 2017

Jessica A Hetherington

6

1 reference

14 September 2017

Phillip J Smith

7

1 reference

14 September 2017

David A Fishman

8

1 reference

14 September 2017

language of work or name

English

0 references

publication date

6 January 2010

1 reference

14 September 2017

1 reference

14 September 2017

volume

117

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

88-95

1 reference

14 September 2017

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Stage I endometrial adenocarcinoma: treatment results in 835 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Undifferentiated carcinoma of the endometrium. A histopathologic and clinical study of 31 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Dissemination and growth of cancer cells in metastatic sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lipid characteristics in metastatic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

The tumor microenvironment: key to early detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

The emerging role of lysophosphatidic acid in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophosphatidic acid is a bioactive mediator in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: over-expression of the high-affinity receptor edg4 in differentiated thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

S1P regulation of ovarian carcinoma invasiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Identification of p2y9/GPR23 as a Novel G Protein-coupled Receptor for Lysophosphatidic Acid, Structurally Distant from the Edg Family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Abnormal serum lysophospholipids in multiple myeloma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

The significance of plasma lysophospholipids in patients with renal failure on hemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

LPA receptor 2 mediates LPA-induced endometrial cancer invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

A new mathematical model for relative quantification in real-time RT-PCR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Hepatocyte growth factor (HGF) induces invasion of endometrial carcinoma cell lines in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

The bioactive phospholipid lysophosphatidic acid is released from activated platelets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophospholipid interactions with protein targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophosphatidic acid induces clonal generation of mouse neurospheres via proliferation of Sca-1- and AC133-positive neural progenitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophosphatidic acid and apoptosis of nerve growth factor-differentiated PC12 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophosphatidic acid possesses dual action in cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophosphatidic acid induces human natural killer cell chemotaxis and intracellular calcium mobilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Activation of p21-activated kinase 1 is required for lysophosphatidic acid-induced focal adhesion kinase phosphorylation and cell motility in human melanoma A2058 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophosphatidic acid enhances epithelial ovarian carcinoma invasion through the increased expression of interleukin-8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Structure and function of matrix metalloproteinases and TIMPs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Matrix metalloproteinases as therapeutic targets in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Activated matrix metalloproteinase-2--a potential marker of prognosis for epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma--a clinicopathologic study using immunohistochemistry and mRNA in situ hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Metastatic potential correlates with enzymatic degradation of basement membrane collagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Endometrial tumor invasiveness is related to metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expressions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Effects of hepatocyte growth factor on the expression of matrix metalloproteinases and their tissue inhibitors during the endometrial cancer invasion in a three-dimensional coculture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Localization of matrix metalloproteinases on endometrial cancer cell invasion in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

MT1-MMP and MMP-7 in invasion and metastasis of human cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Inhibition of matrilysin expression by antisense or RNA interference decreases lysophosphatidic acid-induced epithelial ovarian cancer invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Expression and tissue localization of matrix metalloproteinase 7 (matrilysin) in human gastric carcinomas. Implications for vessel invasion and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

Lysophosphatidic acid induces necrosis and apoptosis in hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.12.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YGYNO.2009.12.012

1 reference

14 September 2017

1 reference